4G4G genotype of the plasminogen activator inhibitor-1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia

被引:30
|
作者
Binder, A.
Endler, G.
Mueller, M.
Mannhalter, C.
Zenz, W.
机构
[1] Med univ Graz, Dept Gen Paediat, A-8036 Graz, Austria
[2] Med Univ Vienna, Inst Clin Med, Vienna, Austria
[3] Med Univ Vienna, Chem Lab Diagnost, Vienna, Austria
关键词
disseminated intravascular coagulation; fibrinogen; meningococcal disease; PAI-1; platelet count; polymorphism;
D O I
10.1111/j.1538-7836.2007.02724.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Meningococcal disease may present as sepsis, meningitis or a combination of both. Impaired fibrinolysis and massive elevation of the plasminogen activator inhibitor-1 (PAI-1) is a characteristic feature of meningococcal sepsis. We and others have reported an association between mortality and the functional 4G/5G promoter polymorphism of the PAI-1 gene in children with meningococcal sepsis. Objective: Multicenter study to investigate the association of the 4G/5G PAI-1 polymorphism and disseminated intravascular coagulation (DIC) in children with meningococcal disease in a Central European population. Patients/Methods: Blood samples and clinical information of 326 previously healthy children with meningococcal infection were collected from 95 pediatric hospitals in Germany, Switzerland, Italy, and Austria from 2000 to 2002. Results: DIC, defined as platelet counts below 100 G L-1, increased D-dimer levels and prolonged prothrombin time, was significantly associated with the 4G4G genotype [31 of 63 (49%) vs. 55 of 175 (31%), P = 0.014], resulting in a hazard ratio (HR) of 1.5 (95% confidence interval 1.1-2.1) to develop DIC. Carriers of the 4G4G genotype showed significantly lower platelet counts (183 G L-1 vs. 227 G L-1, P = 0.009) on admission. Fibrinogen and C-reactive protein levels were not associated with the PAI-1 4G/5G polymorphism, nor were white blood cell counts. Conclusions: Our data show a correlation between the 4G4G genotype of the PAI-1 gene and development of DIC in meningococcal infection.
引用
收藏
页码:2049 / 2054
页数:6
相关论文
共 50 条
  • [41] Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population
    Bucková, D
    Hollá, LI
    Vácha, J
    ALLERGY, 2002, 57 (05) : 446 - 448
  • [42] Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Contributes to Osteonecrosis of the Femoral Head Susceptibility: Evidence from a Systematic Review and Meta-analysis
    Sobhan, Mohammad R.
    Mahdinezhad-Yazdi, Masoud
    Moghimi, Mansour
    Aghili, Kazem
    Jafari, Mohammadali
    Zare-Shehneh, Masoud
    Neamatzadeh, Hossein
    ARCHIVES OF BONE AND JOINT SURGERY-ABJS, 2018, 6 (06): : 468 - 477
  • [43] The 4G/5G promotor polymorphism of the plasminogen activator inhibitor-1 gene and late lumen loss after coronary stent placement in smoking and nonsmoking patients
    Ortlepp, JR
    Hoffmann, R
    Killian, A
    Lauscher, J
    Merkelbach-Bruse, S
    Hanrath, P
    CLINICAL CARDIOLOGY, 2001, 24 (09) : 585 - 591
  • [44] Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the-675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population
    Lomeli-Nieto, Jose Alvaro
    Munoz-Valle, Jose Francisco
    Navarro-Zarza, Jose Eduardo
    Banos-Hernandez, Christian Johana
    Gutierrez-Brito, Jesus Alberto
    Renteria-Cabrera, Valeria
    Horta-Chavez, Eduardo Arturo
    Morales-Nunez, Jose Javier
    Garcia-Arellano, Samuel
    Parra-Rojas, Isela
    Hernandez-Bello, Jorge
    LIFE-BASEL, 2024, 14 (09):
  • [45] Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke - Replicated findings in two nested case-control studies based on independent cohorts
    Wiklund, PG
    Nilsson, L
    Ardnor, SN
    Eriksson, P
    Johansson, L
    Stegmayr, B
    Hamsten, A
    Holmberg, D
    Asplund, K
    STROKE, 2005, 36 (08) : 1661 - 1665
  • [46] Plasminogen Activator Inhibitor-1-675 4G/5G Polymorphism and Polycystic Ovary Syndrome Risk: A Meta Analysis
    Liu, Ying
    Sun, Mei-Guo
    Jiang, Rong
    Ding, Rui
    Che, Zhen
    Chen, Yan-Yan
    Yao, Ci-Jiang
    Zhu, Xiao-Xia
    Cao, Ji-Yu
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2014, 31 (03) : 363 - 370
  • [47] Plasminogen activator inhibitor-1 4G/5G genotype and residual venous occlusion following acute unprovoked deep vein thrombosis of the lower limb: A prospective cohort study
    Giurgea, Georgiana-Aura
    Brunner-Ziegler, Sophie
    Jilma, Bernd
    Sunder-Plassmann, Raute
    Koppensteiner, Renate
    Gremmel, Thomas
    THROMBOSIS RESEARCH, 2017, 153 : 71 - 75
  • [48] Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly
    Mikkelsson, J
    Perola, M
    Wartiovaara, U
    Peltonen, L
    Palotie, A
    Penttilä, A
    Karhunen, PJ
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (01) : 78 - 82
  • [49] Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility A meta-analysis
    Zhang, Xin
    Gao, Bai
    Xu, Bing
    MEDICINE, 2020, 99 (50) : E23660
  • [50] Plasminogen Activator Inhibitor 1 4G/5G and-844G/A Variants in Idiopathic Recurrent Pregnancy Loss
    Magdoud, Kalthoum
    Herbepin, Viviana G.
    Touraine, Renaud
    Almawi, Wassim Y.
    Mahjoub, Touhami
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2013, 70 (03) : 246 - 252